Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Alzheimer's Disease Health Center

Font Size

Alzheimer's Vaccine Gets Second Wind

New Clues Point to Safer Vaccine, Effective Treatment


Big help comes from another research group led by JoAnne McLaurin, PhD, at Canada's University of Toronto. This team was the first to show that the Elan vaccine could improve Alzheimer's symptoms in mice. Now they have the found the key to why the vaccine works, why it causes brain inflammation, and -- most important -- how it might be improved.

In the same issue of Nature Medicine, the McLaurin team reports that a small piece of Aß42 -- Aß4-10 -- raises the same plaque-stopping antibodies as the larger molecule. And in mouse studies, it doesn't cause brain inflammation. Some part of the larger molecule apparently triggers immune responses linked to inflammation.

McLaurin says it looks like the small segment of amyloid protein attacked by anti-Aß4-10 antibodies may be the main troublemaker in Alzheimer's disease. This target appears to be essential for amyloid to self-assemble into plaque.

"The theory -- and I stress that this is only a theory -- is that the anti-Aß4-10 antibody targets an amyloid assembly product, and by pricking out this one product you stop neuronal loss," McLaurin tells WebMD.

It may be that using Aß4-10 as a vaccine would be safer and as effective as the previous version of the Elan vaccine. On the other hand, Nitsch says, it might be better to treat patients with antibody itself -- a strategy known as passive immunization. Or it might be possible to give the vaccine along with drugs to prevent brain inflammation.

McLaurin's team is working on another approach. They're looking for a small molecule that mimics anti-Aß4-10 antibodies. The hope is that such a drug would be small enough to penetrate the brain and stop Alzheimer's disease cold in its tracks. And since people vary enormously in their response to vaccines, an anti-Aß4-10-like drug likely would work for more patients.

What kind of hope does this offer for people who have Alzheimer's disease today? McLaurin warns that research is still in its early stages, but she holds out hope that this approach might work.

"Someone who has florid Alzheimer's disease right now is probably too far along," she says. "But someone in the early stages of the disease has potential to be in clinical trials that will come along. Potentially it will halt the disease -- but it won't bring back anything that they have lost."-->

1 | 2

Today on WebMD

Remember your finger
When it’s more than just forgetfulness.
senior man with serious expression
Which kinds are treatable?
senior man
Common symptoms to look for.
mri scan of human brain
Can drinking red wine reverse the disease?
eating blueberries
Colored mri of brain
Close up of elderly couple holding hands
mature woman
Woman comforting ailing mother
Senior woman with serious expression